Dr. Tatsuya Yamashita published a paper on J Gastroenterol..

REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.

J Gastroenterol. 2020 Jan;55(1):113-122. doi: 10.1007/s00535-019-01642-1.

https://www.ncbi.nlm.nih.gov/pubmed/31720835